PM360

JULY 13, 2023

Our lead indications are HER2-positive metastatic breast cancer (mBC) and metastatic castration-resistant prostate cancer (mCRPC). The leading therapies are now being studied in the clinic and we could see approved therapeutics in the next few years, followed by a rapid expansion into many indications as the technology matures.

Patients 98

Patients Engineering Side effects Leads 98

PM360

APRIL 22, 2024

With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience. In one survey, only 12% of HCPs said they felt biopharma companies are very effective at providing HCP education and training to them.

Education 59

Education Physicians Healthcare Healthcare 59

PM360

NOVEMBER 12, 2024

One in three people is expected to develop a neurological condition in their lifetime, and neurological diseases are the leading cause of disability. healthcare system over $800 billion annually. From your work on the AstraMerck merger to your leadership at Alnylam, you’ve been in the biopharma industry for over 30 years.

Food and Drug Administration 52

Food and Drug Administration Healthcare Provider Healthcare Healthcare 52

PM360

JUNE 24, 2024

This fuels an enormous need for effective patient communication and education as new therapies move through the biopharma pipeline. With this in mind, our efforts to reach these people should focus on providing answers, information, and hope—with all the necessary caveats. Many people, cumulatively, are affected.

Marketing 52

Marketing Patients Food and Drug Administration Digital Media 52

European Pharmaceutical Review

DECEMBER 21, 2022

Furthermore, entire value chains must be redesigned and the CO 2 emitters (especially point source emitters), chemical industry and power sector, downstream users, eg, healthcare industries and their customers, and healthcare providers need to be coordinated, informed, sensitised and must work out contractual frameworks to de-risk the investments.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

PM360

JANUARY 24, 2025

In the pharmaceutical sector, this evolved further with privacycompliant data enrichment, enabling hyper-personalized messaging for healthcare providers (HCPs). This alignment leads to smarter, more impactful HCP interactions. Omnichannel strategies dont just enhance HCP experiences, they empower sales teams, too.

Marketing 52

Marketing Sales Pharmaceutical CRM 52

Clarivate

APRIL 24, 2023

These developments, together with Walgreens’ recent rollout of Health Corners that help patients manage chronic conditions and its October 2022 announcement that it would fully acquire CareCentrix (a platform that coordinates post-acute and home care), underscore Walgreens’ plans to become a leading healthcare provider.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Clarivate

MARCH 14, 2024

Research is raising concerns about PFAS use Similarly, PFAS (per- and polyfluoroalkyl substances) in pharmaceutical packaging have recently come under scrutiny, leading to significant regulatory changes. With Europe taking the lead in introducing draft regulations on PFAS, will other countries and regions implement their own regulations?

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

PM360

DECEMBER 14, 2023

A New Online Destination for HCPs HealthCentral Corporation , operator of leading digital platforms that serve patients living with chronic illness, their care partners, and health professionals, has announced the newest addition to its suite of HCP support sites: MedCentral.

Physicians 52

Physicians Pharma Medical Patients 52

Silver Line CRM

SEPTEMBER 24, 2020

Through contracting with pharmaceutical and biotech companies, VMS BioMarketing provides clinical educator solutions focused on empowering healthcare providers and patients through product support, education, and training. Yet, VMS leads the clinical educator market in patient confidence to start and maintain therapy.

Education 52

Education Healthcare Healthcare Patients 52

PM360

AUGUST 24, 2023

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Braun Medical, Inc.

Marketing 52

Marketing Pharmaceutical Healthcare Healthcare 52

PM360

OCTOBER 22, 2024

DANNY SIGURDSON CEO and Founder Courier Health To effectively engage patients and prescribers to improve overall adherence to prescribed medication regimens, biopharma companies first need the visibility and full context of where a patient stands in their treatment journey. Support healthcare providers in a real and personal way.

Education 52

Education Side effects Medical Patients 52

Pharmaceutical Representative Training

JANUARY 29, 2025

The existence of biosimilars is meant to address both the cost and access of biologics in the healthcare industry. [1] Companies will have to make an effort to communicate with these healthcare professionals, informing them of their product and helping them feel more confident in recommending it to their patients.

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Clarivate

DECEMBER 6, 2022

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Bill Melville, Lead Healthcare Research Analyst. In a fiercely competitive U.S.

Networking 52

Networking Healthcare Healthcare Competition 52

PM360

JUNE 11, 2022

Regardless of the tactics and strategies employed, I would encourage more biopharma professionals to get personally involved in patient engagement programs. A Patient-Centric Month Leads to Results. Nothing contributes more to a good reputation than being approachable and vulnerable.

Patients 59

Patients Pharma Education Media 59

Pharmaceutical Technology

FEBRUARY 20, 2023

This may lead to therapies and dosing regimes being less suitable for minority populations – and according to Hans Bunschoten, chief strategy officer at clinical research company Cerba Research, part of Cerba Healthcare, this is a major problem. participation of white subjects.

Healthcare 52

Healthcare Healthcare Medicine Biopharma 52

Pharmaceutical Technology

FEBRUARY 20, 2023

Mario Papillon, CEO of Cerba Research comments: “ This MoU is an important milestone with Teddy Lab which demonstrates our commitment to expand our footprint into new geographic territories and to best support our global biopharma customers in their evolving needs.

Medicine 52

Medicine Government Healthcare Healthcare 52